These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 88105)

  • 1. Induction of unresponsiveness to skin allografts with donor-strain platelets in antilymphocyte-serum-treated mice.
    Kapnick SJ; Monaco AP
    Transplant Proc; 1979 Mar; 11(1):982-5. PubMed ID: 88105
    [No Abstract]   [Full Text] [Related]  

  • 2. Active enhancement of dog kidney allografts using ALG and donor platelets.
    Rowiński W; Ryffa T; Stepkowski S; Woźniewicz B; Ruka M; Wasowska B; Hay M; Olszewski W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1013-9. PubMed ID: 373670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reduction of antigenicity of heterologous antilymphocyte serum with acid Taka-protease.
    Amemiya H; Yokoyama T; Torisu M; Putnam CW; Anderson JT; Starzl TE
    Clin Exp Immunol; 1972 May; 11(1):67-81. PubMed ID: 4624986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies in rodents on the use of polyclonal antilymphocyte serum and donor-specific bone marrow to induce specific unresponsiveness to skin allografts.
    Monaco AP
    Transplant Proc; 1991 Aug; 23(4):2061-7. PubMed ID: 1871820
    [No Abstract]   [Full Text] [Related]  

  • 6. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
    [No Abstract]   [Full Text] [Related]  

  • 7. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet-induced donor-specific unresponsiveness to kidney allografts in mongrel dogs treated with ALG.
    Rowinski W; Ryffa T; Ruke M; Wasowska B; Tilney NL; Olszewski WL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):586-8. PubMed ID: 6168052
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific unresponsiveness to skin allografts in mice. IV. Immunological reactivity of mice treated with liver extracts, Bordetella pertussis, and antilymphocyte serum.
    Brooks CG; Brent L; Kilshaw PJ; New RR; Pinto M
    Transplantation; 1975 Feb; 19(2):134-44. PubMed ID: 235163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergy between antigen, antilymphocyte serum, and procarbazine hydrochloride in murine skin allotransplantation.
    Brent L; Opara SC
    Transplant Proc; 1979 Mar; 11(1):1019-22. PubMed ID: 377603
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
    Brochier J; Fries D
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerance of skin allografts incompatible at the entire H-2 complex induced in adult mice by the post-transplant treatment.
    Chutná J; Holán V; Sládecek M; Hasek M
    Folia Biol (Praha); 1986; 32(2):154-8. PubMed ID: 3522287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
    Wood ML; Monaco AP
    J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 17. A standardized ALG for use in man.
    Thomas J; Hume DM
    Transplant Proc; 1972 Dec; 4(4):477-9. PubMed ID: 4118964
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of donor-specific antigen for the induction of immunologic unresponsiveness to experimental and clinical allografts.
    Monaco AP; Wood ML; Maki T; Gozzo JJ; DeFazio S
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):122-30. PubMed ID: 3279606
    [No Abstract]   [Full Text] [Related]  

  • 19. Survey of the current status of the clinical uses of antilymphocyte serum.
    Monaco AP; Codish SD
    Surg Gynecol Obstet; 1976 Mar; 142(3):417-26. PubMed ID: 766248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus.
    Hale D; Gottschalk R; Maki T; Monaco AP
    Transplant Proc; 1998 Aug; 30(5):2432-4. PubMed ID: 9723527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.